These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26816820)

  • 1. Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists.
    Gravina GL; Di Sante S; Limoncin E; Mollaioli D; Ciocca G; Carosa E; Sanità P; Di Cesare E; Lenzi A; Jannini EA
    Transl Androl Urol; 2015 Apr; 4(2):139-47. PubMed ID: 26816820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen replacement in men undergoing treatment for prostate cancer.
    Rhoden EL; Averbeck MA; Teloken PE
    J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany.
    Kühn CM; Strasser H; Romming A; Wullich B; Goebell PJ
    Urol Int; 2015; 95(2):153-9. PubMed ID: 25677365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer.
    Millar AC; Elterman DS; Goldenberg L; Van Asseldonk B; Curtis A; Jarvi K
    Can Urol Assoc J; 2016; 10(5-6):181-184. PubMed ID: 27713795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is testosterone a friend or a foe of the prostate?
    Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
    J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR
    Gravina GL; Marampon F; Sanità P; Festuccia C; Forcella C; Scarsella L; Jitariuc A; Vetuschi A; Sferra R; Colapietro A; Carosa E; Dolci S; Lenzi A; Jannini EA
    Oncotarget; 2017 Dec; 8(69):113792-113806. PubMed ID: 29371946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era of testosterone and prostate cancer: from physiology to clinical implications.
    Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
    Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism.
    Gray H; Seltzer J; Talbert RL
    Am J Health Syst Pharm; 2015 Apr; 72(7):536-41. PubMed ID: 25788507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.
    Yassin A; Salman M; Talib RA; Yassin DJ
    Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Therapy Among Prostate Cancer Survivors.
    Nguyen TM; Pastuszak AW
    Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
    Jensen CF; Fode M; Østergren P; Sønksen J
    Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone and prostate cancer: revisiting old paradigms.
    Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
    Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL; Averbeck MA
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.